Anjana Gupta

1.0k total citations
16 papers, 789 citations indexed

About

Anjana Gupta is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Anjana Gupta has authored 16 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Hematology. Recurrent topics in Anjana Gupta's work include Multiple Myeloma Research and Treatments (7 papers), Peptidase Inhibition and Analysis (4 papers) and Ubiquitin and proteasome pathways (4 papers). Anjana Gupta is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Peptidase Inhibition and Analysis (4 papers) and Ubiquitin and proteasome pathways (4 papers). Anjana Gupta collaborates with scholars based in United States, India and France. Anjana Gupta's co-authors include Babatunde O. Oyajobi, Steve Muñoz, Gregory R. Mundy, Ming Zhao, Barry G. Grubbs, Paul J. Williams, Beryl Story, Giovanni Franchin, Di Chen and Barbara Sherry and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Anjana Gupta

16 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anjana Gupta United States	10	428	276	237	186	128	16	789
Carlo Calissano United States	10	109 0.3×	205 0.7×	123 0.5×	208 1.1×	375 2.9×	15	956
Brenda R. Baldwin United States	13	129 0.3×	357 1.3×	480 2.0×	98 0.5×	112 0.9×	17	943
Sudhir Tauro United Kingdom	14	338 0.8×	234 0.8×	475 2.0×	124 0.7×	268 2.1×	39	1.1k
Chiara Gentilini Germany	14	396 0.9×	177 0.6×	252 1.1×	37 0.2×	605 4.7×	24	932
Bergerat Jp France	14	125 0.3×	136 0.5×	164 0.7×	47 0.3×	140 1.1×	42	536
Rita Tognellini Italy	9	249 0.6×	113 0.4×	256 1.1×	39 0.2×	411 3.2×	12	712
Paolo Peterlongo Italy	13	231 0.5×	450 1.6×	198 0.8×	64 0.3×	206 1.6×	31	1.0k
Dalia Salem Egypt	12	105 0.2×	94 0.3×	153 0.6×	53 0.3×	172 1.3×	25	497
Claire Abbal France	8	244 0.6×	84 0.3×	233 1.0×	239 1.3×	319 2.5×	12	716
Frank J. Ward United Kingdom	15	176 0.4×	148 0.5×	103 0.4×	23 0.1×	474 3.7×	34	782

Countries citing papers authored by Anjana Gupta

Since Specialization

Citations

This map shows the geographic impact of Anjana Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anjana Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anjana Gupta more than expected).

Fields of papers citing papers by Anjana Gupta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anjana Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anjana Gupta. The network helps show where Anjana Gupta may publish in the future.

Co-authorship network of co-authors of Anjana Gupta

This figure shows the co-authorship network connecting the top 25 collaborators of Anjana Gupta. A scholar is included among the top collaborators of Anjana Gupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anjana Gupta. Anjana Gupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Sharma, Ramaswamy, Paul J. Williams, Anjana Gupta, et al.. (2015). A dominant-negative F-box deleted mutant of E3 ubiquitin ligase, β-TrCP1/FWD1, markedly reduces myeloma cell growth and survival in mice. Oncotarget. 6(25). 21589–21602. 12 indexed citations

Gupta, Anjana, et al.. (2013). Bilateral ovarian actinomycosis masquerading as ovarian malignancy; without any history of intra-uterine contraceptive device. SHILAP Revista de lepidopterología. 6(4). 468–468. 1 indexed citations

Gupta, Anjana, et al.. (2013). Lipoblastoma: A rare benign, pediatric soft tissue tumor. SHILAP Revista de lepidopterología. 6(3). 305–305. 2 indexed citations

Dairaghi, Daniel J., Babatunde O. Oyajobi, Anjana Gupta, et al.. (2012). CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease. Blood. 120(7). 1449–1457. 62 indexed citations

Oyajobi, Babatunde O., Anjana Gupta, Monica Mann, & Addanki P. Kumar. (2011). Abstract 4216: Antitumor effect of Nexrutine, a phellodendron amurense bark extract, in multiple myeloma. Cancer Research. 71(8_Supplement). 4216–4216. 1 indexed citations

Kochar, Dhanpat Kumar, Gajanand Singh Tanwar, Sanjay Kumar Kochar, et al.. (2010). Clinical Features of Children Hospitalized with Malaria—A Study from Bikaner, Northwest India. American Journal of Tropical Medicine and Hygiene. 83(5). 981–989. 117 indexed citations

Kochar, Dhanpat Kumar, Ashis Das, Abhishek Kochar, et al.. (2010). Thrombocytopenia inPlasmodium falciparum,Plasmodium vivaxand mixed infection malaria: A study from Bikaner (Northwestern India). Platelets. 21(8). 623–627. 70 indexed citations

Oyajobi, Babatunde O., Daniel J. Dairaghi, Anjana Gupta, et al.. (2010). CCR1 Blockade by An Orally-Available CCR1 Antagonist Reduces Tumor Burden and Osteolysis In Vivo In a Mouse Model of Myeloma Bone Disease. Blood. 116(21). 3000–3000. 4 indexed citations

Gupta, Anjana, Christi Wideman, Brandon McCluskey, et al.. (2008). Bortezomib significantly delays development of paraplegia in the 5TGM1 murine model of myeloma bone disease. Cancer Research. 68. 3267–3267. 1 indexed citations

10.

Murillo, Oihana, Ainhoa Arina, Sandra Hervás‐Stubbs, et al.. (2008). Therapeutic Antitumor Efficacy of Anti-CD137 Agonistic Monoclonal Antibody in Mouse Models of Myeloma. Clinical Cancer Research. 14(21). 6895–6906. 54 indexed citations

11.

Oyajobi, Babatunde O., I. Ross Garrett, Anjana Gupta, et al.. (2007). Stimulation of new bone formation by the proteasome inhibitor, bortezomib: implications for myeloma bone disease. British Journal of Haematology. 139(3). 434–438. 81 indexed citations

12.

Oyajobi, Babatunde O., Steve Muñoz, Paul J. Williams, et al.. (2007). Detection of myeloma in skeleton of mice by whole-body optical fluorescence imaging. Molecular Cancer Therapeutics. 6(6). 1701–1708. 48 indexed citations

13.

Sterling, Julie A., Babatunde O. Oyajobi, Barry G. Grubbs, et al.. (2006). The Hedgehog Signaling Molecule Gli2 Induces Parathyroid Hormone-Related Peptide Expression and Osteolysis in Metastatic Human Breast Cancer Cells. Cancer Research. 66(15). 7548–7553. 110 indexed citations

14.

Oyajobi, Babatunde O., Giovanni Franchin, Paul J. Williams, et al.. (2003). Dual effects of macrophage inflammatory protein-1α on osteolysis and tumor burden in the murine 5TGM1 model of myeloma bone disease. Blood. 102(1). 311–319. 160 indexed citations

15.

Dawson, Dawn, et al.. (2002). Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells. Oncogene. 21(1). 78–86. 63 indexed citations

16.

Stephenson, Katherine, Anjana Gupta, Shamimunisa B. Mustafa, & Glenn A. Halff. (1997). Endothelin-Stimulated Nitric Oxide Production in the Isolated Kupffer Cell. Journal of Surgical Research. 73(2). 149–154. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact